Eric Zhang1, Jin Choul Chai1, Amy A Deik2, Simin Hua1, Anjali Sharma1,3, Michael F Schneider4, Deborah Gustafson5, David B Hanna1, Jordan E Lake6, Leah H Rubin4,7, Wendy S Post4,8, Kathryn Anastos1,3, Todd Brown9, Clary B Clish2, Robert C Kaplan1,10, Qibin Qi1,11. 1. Department of Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, NY, USA. 2. Broad Institute of MIT and Harvard, Cambridge, MA, USA. 3. Department of Medicine, Albert Einstein College of Medicine, Bronx, NY, USA. 4. Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA. 5. Department of Neurology, State University of New York-Downstate Medical Center, Brooklyn, NY, USA. 6. Division of Infectious Diseases, Department of Internal Medicine, McGovern Medical School at UTHealth, Houston, TX, USA. 7. Department of Neurology and Psychiatry, Johns Hopkins University School of Medicine, Baltimore, MD, USA. 8. Division of Cardiology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA. 9. Division of Endocrinology, Diabetes, and Metabolism, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA. 10. Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle WA, USA. 11. Department of Nutrition, Harvard T.H. Chan School of Public Health, Boston, MA, USA.
Abstract
OBJECTIVES: Antiretroviral therapy (ART) use is associated with disrupted lipid and glucose metabolism in people with HIV infection. We aimed to identify plasma lipid species associated with risk of diabetes in the context of HIV infection. RESEARCH DESIGN AND METHODS: We profiled 211 plasma lipid species in 491 HIV-infected and 203 HIV-uninfected participants aged 35 to 55 years from the Women's Interagency HIV Study and the Multicenter AIDS Cohort Study. Cox proportional hazards model was used to examine associations between baseline lipid species and incident diabetes (166 diabetes cases were identified during a median follow-up of 12.6 years). RESULTS: We identified 11 lipid species, representing independent signals for 8 lipid classes/subclasses, associated with risk of diabetes (P < 0.05 after FDR correction). After adjustment for multiple covariates, cholesteryl ester (CE) (22:4), lysophosphatidylcholine (LPC) (18:2), phosphatidylcholine (PC) (36:4), phosphatidylcholine plasmalogen (34:3), and phosphatidylethanolamine (PE) (38:2) were associated with decreased risk of diabetes (HRs = 0.70 to 0.82 per SD increment), while diacylglycerol (32:0), LPC (14:0), PC (38:3), PE (36:1), and triacylglycerol (50:1) were associated with increased risk of diabetes (HRs = 1.26 to 1.56 per SD increment). HIV serostatus did not modify any lipid-diabetes associations; however, most of these lipid species were positively associated with HIV and/or ART use, including 3 diabetes-decreased ( CE [22:4], LPC [18:2], PE [38:2]) and all 5 diabetes-increased lipid species. CONCLUSIONS: This study identified multiple plasma lipid species associated with incident diabetes. Regardless of the directions of their associations with diabetes, most diabetes-associated lipid species were elevated in ART-treated people with HIV infection. This suggests a complex role of lipids in the link between ART and diabetes in HIV infection.
OBJECTIVES: Antiretroviral therapy (ART) use is associated with disrupted lipid and glucose metabolism in people with HIV infection. We aimed to identify plasma lipid species associated with risk of diabetes in the context of HIV infection. RESEARCH DESIGN AND METHODS: We profiled 211 plasma lipid species in 491 HIV-infected and 203 HIV-uninfected participants aged 35 to 55 years from the Women's Interagency HIV Study and the Multicenter AIDS Cohort Study. Cox proportional hazards model was used to examine associations between baseline lipid species and incident diabetes (166 diabetes cases were identified during a median follow-up of 12.6 years). RESULTS: We identified 11 lipid species, representing independent signals for 8 lipid classes/subclasses, associated with risk of diabetes (P < 0.05 after FDR correction). After adjustment for multiple covariates, cholesteryl ester (CE) (22:4), lysophosphatidylcholine (LPC) (18:2), phosphatidylcholine (PC) (36:4), phosphatidylcholine plasmalogen (34:3), and phosphatidylethanolamine (PE) (38:2) were associated with decreased risk of diabetes (HRs = 0.70 to 0.82 per SD increment), while diacylglycerol (32:0), LPC (14:0), PC (38:3), PE (36:1), and triacylglycerol (50:1) were associated with increased risk of diabetes (HRs = 1.26 to 1.56 per SD increment). HIV serostatus did not modify any lipid-diabetes associations; however, most of these lipid species were positively associated with HIV and/or ART use, including 3 diabetes-decreased ( CE [22:4], LPC [18:2], PE [38:2]) and all 5 diabetes-increased lipid species. CONCLUSIONS: This study identified multiple plasma lipid species associated with incident diabetes. Regardless of the directions of their associations with diabetes, most diabetes-associated lipid species were elevated in ART-treated people with HIV infection. This suggests a complex role of lipids in the link between ART and diabetes in HIV infection.
Authors: David B Hanna; Wendy S Post; Jennifer A Deal; Howard N Hodis; Lisa P Jacobson; Wendy J Mack; Kathryn Anastos; Stephen J Gange; Alan L Landay; Jason M Lazar; Frank J Palella; Phyllis C Tien; Mallory D Witt; Xiaonan Xue; Mary A Young; Robert C Kaplan; Lawrence A Kingsley Journal: Clin Infect Dis Date: 2015-04-22 Impact factor: 9.079
Authors: Cristina Razquin; Estefanía Toledo; Clary B Clish; Miguel Ruiz-Canela; Courtney Dennis; Dolores Corella; Christopher Papandreou; Emilio Ros; Ramon Estruch; Marta Guasch-Ferré; Enrique Gómez-Gracia; Montserrat Fitó; Edward Yu; José Lapetra; Dong Wang; Dora Romaguera; Liming Liang; Angel Alonso-Gómez; Amy Deik; Mónica Bullo; Lluis Serra-Majem; Jordi Salas-Salvadó; Frank B Hu; Miguel A Martínez-González Journal: Diabetes Care Date: 2018-10-16 Impact factor: 19.112
Authors: Dagmar Drogan; Warwick B Dunn; Wanchang Lin; Brian Buijsse; Matthias B Schulze; Claudia Langenberg; Marie Brown; Anna Floegel; Stefan Dietrich; Olov Rolandsson; David C Wedge; Royston Goodacre; Nita G Forouhi; Stephen J Sharp; Joachim Spranger; Nick J Wareham; Heiner Boeing Journal: Clin Chem Date: 2014-12-18 Impact factor: 8.327
Authors: David B Hanna; Juan Lin; Wendy S Post; Howard N Hodis; Xiaonan Xue; Kathryn Anastos; Mardge H Cohen; Stephen J Gange; Sabina A Haberlen; Sonya L Heath; Jason M Lazar; Chenglong Liu; Wendy J Mack; Igho Ofotokun; Frank J Palella; Phyllis C Tien; Mallory D Witt; Alan L Landay; Lawrence A Kingsley; Russell P Tracy; Robert C Kaplan Journal: J Infect Dis Date: 2017-05-01 Impact factor: 7.759
Authors: Wei Zhao; Xueyin Wang; Amy A Deik; David B Hanna; Tao Wang; Sabina A Haberlen; Sanjiv J Shah; Jason M Lazar; Howard N Hodis; Alan L Landay; Bing Yu; Deborah Gustafson; Kathryn Anastos; Wendy S Post; Clary B Clish; Robert C Kaplan; Qibin Qi Journal: Circulation Date: 2019-04-23 Impact factor: 39.918
Authors: Jin Choul Chai; Amy A Deik; Simin Hua; Tao Wang; David B Hanna; Xiaonan Xue; Sabina A Haberlen; Sanjiv J Shah; Yousin Suh; Jason M Lazar; Deborah Gustafson; Howard N Hodis; Alan L Landay; Kathryn Anastos; Wendy S Post; Robert C Kaplan; Clary B Clish; Qibin Qi Journal: JAMA Cardiol Date: 2019-12-01 Impact factor: 30.154
Authors: Rebecca A Ward; Nima Aghaeepour; Roby P Bhattacharyya; Clary B Clish; Brice Gaudillière; Nir Hacohen; Michael K Mansour; Philip A Mudd; Shravani Pasupneti; Rachel M Presti; Eugene P Rhee; Pritha Sen; Andrej Spec; Jenny M Tam; Alexandra-Chloé Villani; Ann E Woolley; Joe L Hsu; Jatin M Vyas Journal: Open Forum Infect Dis Date: 2021-09-25 Impact factor: 3.835
Authors: Elaine A Yu; José O Alemán; Donald R Hoover; Qiuhu Shi; Michael Verano; Kathryn Anastos; Phyllis C Tien; Anjali Sharma; Ani Kardashian; Mardge H Cohen; Elizabeth T Golub; Katherine G Michel; Deborah R Gustafson; Marshall J Glesby Journal: PLoS One Date: 2022-07-08 Impact factor: 3.752
Authors: Antonio Paride Passaro; Pierluigi Marzuillo; Stefano Guarino; Federica Scaglione; Emanuele Miraglia Del Giudice; Anna Di Sessa Journal: World J Diabetes Date: 2021-12-15